Alexandra J. Gadiano

The highly selective dopamine D R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents

Chloe J. Jordan, Bree A. Humburg, M. S. RICE et al. · Neuropharmacology · 2019 · 84 citations · Full text

Medicine, Neuroscience, Pharmacology +12

Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects

Zhi‐Bing You, Guo-Hua Bi, Ewa Galaj et al. · Neuropsychopharmacology · 2018 · 78 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

<i>N</i>-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-<scp>l</scp>-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders

Michael T. Nedelcovych, Lukáš Tenora, Boe-Hyun Kim et al. · Journal of Medicinal Chemistry · 2017 · 68 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Tumor-Targeted Delivery of 6-Diazo-5-oxo-<scp>l</scp>-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs

Lukáš Tenora, Jesse Alt, Ranjeet Prasad Dash et al. · Journal of Medicinal Chemistry · 2019 · 62 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse

Michael T. Nedelcovych, Alexandra J. Gadiano, Ying Wu et al. · ACS Chemical Neuroscience · 2017 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +17